VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH CML 2022 | Design & aims of the EURO-SKI trial in CML

Francois-Xavier Mahon, MD, PhD, University of Bordeaux, Bordeaux, France, briefly outlines the design and objectives of the EURO-SKI (NCT01596114) trial which aimed to better define the prognostic factors for treatment-free remission (TFR) in chronic myeloid leukemia (CML). This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter